Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01320969
Other study ID # 2010-P-002025
Secondary ID
Status Completed
Phase N/A
First received March 17, 2011
Last updated May 4, 2012
Start date December 2010
Est. completion date May 2012

Study information

Verified date May 2012
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

It is well-established that the practice of mindfulness meditation leads to improvements in mental health and well-being and the cultivation of positive emotions. However, the neural mechanisms of these improvements are largely unknown. A few recent studies suggest that mindfulness meditation impacts the structure and function of the ventromedial prefrontal cortex, the hippocampus, and the amygdala. Interestingly, recent studies have shown that these regions are part of a brain circuit that is critical for the extinction of conditioned fear responses, and for the retention of fear extinction memory. Building on the overlap of these regions and on conceptual considerations, the project investigates whether mindfulness meditation could influence one's capacity to retain the memory of fear extinction. Meditation-naïve participants will be randomized to either a mindfulness-meditation based training or an active control training that controls for all mindfulness-unspecific components. Participants will undergo a fear conditioning, extinction and extinction recall protocol in an MRI scanner before and after the trainings. We hypothesize that participants who have practiced mindfulness meditation will show greater improvements in fear extinction memory after the course, and that these improvements will be correlated with anatomical and functional changes in the brain regions of interest. Improvements in fear extinction memory will also be related to improvements in self-reported psychological well-being. Merging the fields of an ancient spiritual tradition and a fundamental learning mechanism, the project investigates the underlying neural mechanisms of a practice for the enhancement of mental health and well-being.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

18-65 years of age Proficient in English Right-handed Free of medication that affect cerebral metabolism Able to give informed consent High stress level (defined as a score of >= 3 on the 4-item Perceived Stress Scale).

Exclusion Criteria:

More than 10 meditation sessions of any tradition in their lifetime, or more than 5 sessions within the last year.

More than 10 yoga sessions of any tradition in their lifetime, or more than 5 sessions within the last year.

History of neurologic or psychiatric disease, substance abuse or dependence that is current or within the last year.

Major/chronic medical conditions History of head injury resulting in prolonged loss of consciousness and/or neurological sequelae History of seizures History of stroke Prior neurosurgical procedure Metal in the body, metal injury to the eyes Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit, or ventriculo-peritoneal shunt Pregnancy; breastfeeding or nursing Claustrophobia Weight > 350 lbs.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-Based Stress Reduction course
an eight-week mindfulness-based stress reduction course

Locations

Country Name City State
United States Massachusetts General Hospital Charlestown Massachusetts

Sponsors (4)

Lead Sponsor Collaborator
Massachusetts General Hospital John Templeton Foundation, Mind and Life Institute, Hadley, Massachusetts, University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in MRI data We will measure the change in functional MRI during fear conditioning, extinction, and extinction retention memory pre to post intervention. Furthermore, we will measure changes in structural MRI data, DTI data and resting state fMRI data. pre and post intervention or wait period; first set of MRIs within 3 weeks before the course, second set of MRIs within 3 weeks after course; MRIs will take 1.5 hours each and will occur on 2 consecutive days No
Secondary change in well-being questionnaire data will also be collected pre and post the intervention / wait period; change in the scores will be assessed pre and post intervention or waitlist period; collected when the MRIs take place; will take about one hour each No
See also
  Status Clinical Trial Phase
Completed NCT06044896 - Physiology of Body Lateralization on Regional Lung Ventilation Study N/A
Completed NCT02101801 - Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers N/A
Recruiting NCT06101641 - Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals N/A
Completed NCT03065283 - Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women N/A
Recruiting NCT01721811 - Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism N/A
Completed NCT01211717 - The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients N/A
Completed NCT01568541 - Fluoride Intake From Toothbrushig With Children's or Regular Toothpastes N/A
Completed NCT04941196 - Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition Phase 1
Completed NCT05541094 - Study of Vitamin D Fortification of Milk and Oil
Completed NCT05597657 - Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals N/A
Completed NCT03728868 - Tolerability and Risk of Adverse Events With a Probiotic Supplement N/A
Recruiting NCT04513782 - The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
Completed NCT05637060 - Bioequivalence Study of Rosuvastatin Tablet N/A
Not yet recruiting NCT05110885 - Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
Completed NCT01134978 - Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study Phase 1
Completed NCT06137534 - Upper Extremity Pattern Exercises and Respiratory Functions N/A
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Enrolling by invitation NCT01872091 - Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy N/A
Completed NCT01872117 - Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters N/A
Completed NCT02409836 - A Study to Assess the Ingestion of Dentifrice by Children N/A

External Links